Phase II Study of STA-2 in Patients With Chronic Stable Angina The objectives of this study are to evaluate the efficacy, pharmacological activities and safety of STA-2 in the treatment of chronic stable angina.

• Country Taiwan, Province of China
• organs None
• Specialty None

Phase IIb Study of STA-2 in Patients With Chronic Stable Angina The objective of this study is to evaluate the dose-response of three different dose levels of STA-2 (900 mg daily, 1800 mg daily and 2700 mg daily for 42 days) versus placebo in patients ...

• Country Taiwan, Province of China
• organs None
• Specialty None